EP2589669
Single nucleotide polymorphisms that predict HCV treatment outcomes
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.4.2011EP published:
22.10.2014EP application number:
13152518.0
EPO information:
European Patent Register
Max expiry date:
10.4.2031
Title:
Single nucleotide polymorphisms that predict HCV treatment outcomes
Timeline
Today
11.4.2011EP application
22.10.2014EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070, Basel, CH
Inventor
Name:
Chu, TomAddress:
Mont Clair, NJ, US
Name:
Essioux, LaurentAddress:
Attenschwiller, FR
Name:
Germer, SorenAddress:
Maplewood, NJ, US
Name:
Lopatin, UriAddress:
San Francisco, CA, US
Name:
Shulman, NancyAddress:
Palo Alto, CA, US
Name:
Thommes, JamesAddress:
San Francisco, CA, US
Priority
Number:
323502 PDate:
13.4.2010Country:
US
Classification
Categories:
C12Q 1/68